YourHealthRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.9/10
Best for: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
YourHealthRx scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
Price checked on YourHealthRx’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform that connects patients with independent clinicians and 503A compounding pharmacies in all 50 states (not DC). Compounded semaglutide is $170/month and tirzepatide $210/month month-to-month, with lower 3- and 6-month upfront plans and the same price at every dose. Oral tablets are also offered. Compounded meds aren't FDA-approved, the pharmacy isn't named, and refunds are rarely available once intake starts.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to YourHealthRx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
YourHealthRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $170/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored YourHealthRx
Each dimension is scored algorithmically from YourHealthRx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $170/mo, YourHealthRx runs about 5% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.3/10YourHealthRx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.5/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
8.2/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.4/10YourHealthRx treats patients in all 50 states.
Support10%
6.0/10YourHealthRx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this YourHealthRx review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $170–$210/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with YourHealthRx
We walked YourHealthRx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Tap Check Your Eligibility and pick a goal, such as weight loss and metabolic health.
- 2Choose your state; the next screen shows GLP-1 options from $140/mo (a rate-lock promo marked as ending Oct 15).
- 3The next step asks for your email before you continue (walk stopped here).
- 4From a medication page you can instead pick a plan length; the partner checkout shows the monthly price and then asks you to accept HIPAA, telehealth, and terms consents to register (walk stopped).
- Monthly, 3-month, and 6-month prices are listed for each medication before any intake; 3- and 6-month plans are one upfront charge.
- The partner checkout lists semaglutide injections at $170/month and tirzepatide at $210/month, covering prescription, medication, and delivery.
- Patients in Arkansas, Kansas, Mississippi, New Jersey, New Mexico, Rhode Island, West Virginia, DC, and Virginia must schedule a video visit.
- The $140/mo promo was still advertised the day after its stated end date.
- The refund policy says refunds are generally unavailable once intake or clinician review has begun.
YourHealthRx customer support
GLP-1 medications YourHealthRx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides YourHealthRx offers
Beyond GLP-1s, YourHealthRx also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Billed monthly; same price at every dose. Longer plans: 3-mo $150/mo ($450), 6-mo $140/mo ($840). Oral tablet $200/mo; 3-mo $180/mo ($540), 6-mo $170/mo ($1,020).
Billed monthly; same price at every dose. Longer plans: 3-mo $200/mo ($600), 6-mo $190/mo ($1,140). Oral tablet $220/mo; 3-mo $190/mo ($570), 6-mo $180/mo ($1,080).
Ready to get started?
Plans and promotions change often, so check YourHealthRx's current pricing and active discounts before you decide.
What we like
- Available in all 50 states through a multi-state licensed clinician network
- Compounded semaglutide and tirzepatide in two formats: weekly injectable or daily oral dissolving tablet
- Flat price that doesn't change as your dose increases
- Prices shown upfront, and the monthly price includes prescription, medication, and delivery
- Lower rates on 3- and 6-month plans, plus a broad peptide catalog and lab testing
Watch-outs
- YourHealthRx is a platform, not the prescriber or pharmacy; prescribing runs through partner clinicians
- Compounded medications are not FDA-approved, and are not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named
- Refunds are generally not available once intake or clinician review has started
- The lowest advertised rates need a 6-month upfront payment or a promo code; month-to-month is $170 (semaglutide) or $210 (tirzepatide)
- Not available in DC, some injectables can't ship to California, and some states require a video visit
- No LegitScript certification displayed
Is YourHealthRx worth it?
YourHealthRx's whole pitch comes down to this: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up. It runs $170/month at every dose, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. Its standout is a needle-free oral option for people who would rather not inject.
On top of the core program, it charges the same price at every dose and includes lab testing.
How much YourHealthRx costs
Compounded semaglutide runs $170/month and compounded tirzepatide runs $210/month.
That's roughly in line with the ~$179/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, HealthRX runs semaglutide and tirzepatide from $165/month, so compare it with YourHealthRx before you commit.
Medications: what YourHealthRx prescribes
YourHealthRx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products, which is the standard trade-off across the compounded-GLP-1 market.
YourHealthRx's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who YourHealthRx is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
YourHealthRx treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
YourHealthRx is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see YourHealthRx against the wider field, use our ranking of semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
YourHealthRx scores highest on state availability and ease of access.
Ready to start with YourHealthRx?
From $170/mo. See current pricing and start your free consultation.
YourHealthRx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare YourHealthRx vs…
YourHealthRx scores7.9/10
Side-by-side pricing, medications and scores. Pick a matchup.
YourHealthRx vs Amazon One Medical
Amazon One Medical scores 8.5/10
YourHealthRx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this YourHealthRx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See YourHealthRx's current pricing
Plans from $170/mo. Start your free consultation to check eligibility and today's price.